Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation

NCT05491343 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Arteriovenous Malformations

Interventions

DRUG: MedroxyPROGESTERone Injection [Depo-Provera]
DEVICE: Other

Sponsor

HaEmek Medical Center, Israel